FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, namely to method for reducing the frequency of relapses of labial herpes in patient, which comprises topical administration of therapeutically effective amount of polyethylene glycol (PEG) as an active agent, which is either (i) PEG with average molecular weight of 200–800, or (ii) mixture of (a) PEG with average molecular weight of 200–800 and (b) PEG with average molecular weight of 1000–15000, wherein the weight ratio (a) to (b) ranges from 3:1 to 20:1, wherein said method is performed for at least 4 weeks; topical administration is carried out 1–5 times a day on the lips and/or around the lips of the patient.
EFFECT: invention provides reduction or prevention of relapses of labial herpes.
53 cl, 1 ex, 9 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HERPES VIRAL INFECTION | 2003 |
|
RU2241443C1 |
| VACCINE AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR TRIGGERING IMMUNE RESPONSE | 2010 |
|
RU2585961C9 |
| METHOD OF THERAPEUTIC INFLUENCE ON PERSONS INFECTED WITH VIRUS OF HERPES | 2007 |
|
RU2359720C2 |
| USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
| METHOD FOR CHOOSING THERAPY IN CASE OF HERPES | 2000 |
|
RU2215292C2 |
| PHARMACEUTICAL COMPOSITION FOR HERPES TREATMENT | 1998 |
|
RU2165264C2 |
| TREATING VIRAL INFECTIONS | 2012 |
|
RU2545918C1 |
| COMPOSITIONS WITH HIGH PENETRATION ABILITY AND METHODS OF TREATING PATHOGENS-INDUCED TISSUE DISORDERS | 2012 |
|
RU2586969C2 |
| METHOD FOR VACCINE THERAPY OF HERPETIC INFECTION | 2012 |
|
RU2514034C2 |
| METHOD OF TREATMENT FOR GENITAL HERPES | 2007 |
|
RU2339377C1 |
